11. O’Connor A, Bennett C, Stacey D, Barry MJ, Col N, Eden K, et al. Decision aids for people facing health treatment or screening decisions;...
12. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview...
13. Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer--United States, 1985. CA Cancer...
14. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National...
15. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific...
16. Roobol MJ, Kerkhof M, Schroder FH, Cuzick J, Sasieni P, Hakama M, et al. Prostate cancer mortality reduction by prostatespecific antigen-based...
17. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al. Screening for prostate cancer: systematic review and...
18. Vickers AJ, Cronin AM, Bjork T, Manjer J, Nilsson PM, Dahlin A, et al. Prostate specific antigen concentration at age 60 and death or...
19. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al. Five-year outcomes after prostatectomy or radiotherapy...
20. American College of Physicions. Clinical Guideline: Part III. Screening for Prostate Cancer. Ann Intern Med 1997; 126:480-4.
21. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of...
22. Ottawa Hospital Research Institute. A to Z inventory of Decision Aids. 2010 [updated 2010; cited]; Available from: http:// decisionaid.ohri.ca/AZinvent.
23. Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, et al. Trials of decision aids for prostate cancer screening: a systematic...
24. Krist AH, Woolf SH, Johnson RE, Kerns JW. Patient education on prostate cancer screening and involvement in decision making. Ann Fam Med...
26. Allen JD, Othus MK, Hart A, Jr., Tom L, Li Y, Berry D, et al. A randomized trial of a computer-tailored decision aid to improve prostate...
27. Rubel SK, Miller JW, Stephens RL, Xu Y, Scholl LE, Holden EW, et al. Testing the effects of a decision aid for prostate cancer screening....
28. Evans R, Joseph-Williams N, Edwards A, Newcombe RG, Wright P, Kinnersley P, et al. Supporting informed decision making for prostate specific...
29. Barry MJ. The prostate cancer treatment bazaar: comment on ”Physician visits prior to treatment for clinically localized prostate cancer”....
30. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Guideline for the management of clinically localized prostate...
31. Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, et al. Initial hormonal management of androgen-sensitive metastatic,...
32. Freedland SJ, Presti JC, Jr., Amling CL, Kane CJ, Aronson WJ, Dorey F, et al. Time trends in biochemical recurrence after radical prostatectomy:...
33. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments...
34. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early...
35. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data....
36. O’Connor AM, Mulley AG, Jr., Wennberg JE. Standard consultations are not enough to ensure decision quality regarding preference-sensitive...
37. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Patient decision aids for prostate cancer treatment: a systematic review of the...
38. Barry MJ, Wescott PH, Reifler EJ, Chang Y, Moulton BW. Reactions of potential jurors to a hypothetical malpractice suit: alleging failure...
39. Legare F, Ratte S, Stacey D, Kryworuchko J, Gravel K, Graham I, et al. Interventions for improving the adoption of shared decision making...
40. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC; Available from: http:// www.iom.edu/Reports/2009/Comparative...
41. International Agency for Research on Cancer. Globocan 2008. Lyon: International Agency for Research on Cancer; 2010 [updated 2010; cited...